Sixty-three Carnpvlobacteriejuni isolates were screened for their resistance to the antibiotics ampicillin, cefaclor, ciprofloxacin, erythromycin, gentarnycin, tetracycline, and trimethoprim-sulfamethoxaZole. Based on this screen, the resistant strains D28a and H2a and the nonresistant strain A24a were selected for evaluation of their resistance and susceptibility to inactivation by cinnamaldehyde and carvacrol, the main constituents of plant-derived cinnamon and oregano oils, respectively. Different concentrations (0.05, 0. 1, and 0.2% [vol/vol] in sterile phosphate-buffered saline) of cinnamaldehyde and carvacrol were added to C. jejuni cultures with initial populations of 10 CFU/ml. The samples were then mixed thoroughly and incubated at 37°C. Viable bacterial populations were enumerated at incubation periods of 0, 30, 60. and 120 mm. The results indicate that the extent of inhibition of microbial survival was related to both the nature and concentration of antimicrobials and the incubation time. Both cinnamaldehyde and carvacrol exhibited rapid antimicrobial activity against both antibiotic-resistant and nonresistant C. jejuni strains, at concentrations of -0.1 % and higher. The antimicrobial efficacy of cinnamaldehyde was greater than that of carvacrol. The possible significance of the results for microbiological food safety is discussed.
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Resistance in foodborne bacteria against standard, widely used antibiotics is a major source of concern to poultry producers, food processors, regulatory agencies, and consumers (16) . For example, Carnpvlobacter strains isolated from poultry abattoir effluent and sewage purification plants were resistant to quinolone antibiotics (9, 11) . Related studies report on the worldwide emergence of resistant Campylobacter isolates in broiler chickens (1, 7, 10, 13, 15) and on the possible risks to humans associated with antibiotic-resistant C. jejuni infections (8, 12, 18) . Still another example is the recent report that human infection by antibiotic-resistant Staphylococcus aureus affected about 90,000 people annually in the United States alone, resulting in -18,000 deaths ( 17).
Compounds derived from plant sources such as essential oils, their active components, spices, and plant extracts have shown antimicrobial effects against a number of foodborne pathogens, including antibiotic-resistant S. aureus, Bacillus cereus, and Escherichia coli, as well as nonpathogenic, antibiotic-resistant Micrococcus luteus (3, 4, 6) . Postulated mechanisms for botanicals involve disruption of cell membranes, and chelation to essential trace elements such as zinc and iron that the bacteria need for growth and synthesis of metal-containing toxins (2, 5, 14) . These mechanisms differ from those of some standard antibiotics such as vancomycin, which acts by inhibiting synthesis of bacterial cell wall proteins. It was therefore of inherent interest to determine whether our studies on the efficacy of plantbased compounds against antibiotic-resistant bacteria could
MATERIALS AND METHODS
Antimicrobial compounds. Carvacrol (>98% pure, M 150.2) and trans-cinnamaldehyde (>99.5% pure, Mr 132.2) were obtained from Sigma-Aldrich (St. Louis, Mo.).
Test organisms. The following strains of C. Jejuni were evaluated: D28a, H2a, and A24a. All these strains are poultry isolates and have been screened for their antibiotic resistance as described below.
Preparation of bacterial cultures and media. C. jejuni isolates were streaked from cryopreserved cells onto Mueller-Hinton agar (BBL, Becton Dickinson, Sparks, Md.), supplemented with 5% citrated bovine blood (Cleveland Scientific. Bath, Ohio) (MHB agar). These plates were incubated at 37°C in a humidified 5% CO2 incubator for 3 days. A single colony was transferred with a sterile loop to Mueller-Hinton broth (BBL. Becton Dickinson) and incubated with shaking in an anaerobic chamber (10% CO2, 10% H2, 80% N 2 ) at 42°C for 24 h. Cells were then harvested by centrifugation (2,000 X g for 10 mm) and washed twice in sterile buffered peptone water (BPW; Difco, Becton Dickinson). Cells were suspended in BPW to a concentration of about 10 CFU/ml and diluted to the required concentration. To enumerate viable organisms after each treatment, dilutions were done in BPW, plating was done on MHB agar, and plates were incubated in a humidified 5% CO 2 incubator at 37°C for 48 to 72 h. Screening of C. jejuni isolates for antibiotic resistance. C. jejuni isolates were screened for antibiotic resistance using E-test strips (AB Biodisk, AB Biodisk North America, Inc., Piscataway, N.J.). The E-tests contained the following antibiotics at the indicated range of concentrations: cefaclor, 0.016 to 256 .Lg/ml; ciprofloxacin, 0.002 to 32 g/ml; tetracycline, 0.0016 to 256 .Lg/ml; erythromycin, 0.016 to 256 pg/ml; gentamicin, 0.016 to 256 pg/ ml; trimethoprim-sulfamethoxazole, 0.002 to 32 p.g/ml; and ampicillin, 0.016 to 256 .Lg/ml. Clinical and Laboratory Standards Institute breakpoints were used when available. For those breakpoints that were not reported by the Clinical and Laboratory Standards Institute for Campylobacter, breakpoints published by the Clinical and Laboratory Standards Institute for other pathogens were used. The breakpoints used for resistance are as follows: cefaclor, 32 .i.g/ml; ciprofloxacin, 4 i.g/mI; tetracycline, 16 p.g/ ml; erythromycin, 32 g/ml; gentamicin. 8 .tgtml; trimethoprimsulfamethoxazole, 4 pgtml, and ampicillin, 32 .Lg/ml.
Isolates were grown on MHB plates and resuspended in phosphate-buffered saline to an OD 6 = 0.80 (equivalent to a McFarland standard of 1.0). A swab of each strain was streaked in a lawn pattern, and an E-test strip for each antibiotic was placed on the plates. The MIC was determined as per the manufacturer's instructions, following incubation at 37°C in a humidified 5% CO2 incubator for 48 to 72h.
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Antimicrobial activities of cinnamaldehyde and carvacrol against C. jejuni strains. The antimicrobial compounds (cinnamaldehyde and carvacrol) were dissolved using sterile phosphatebuffered saline. A stock solution of 0.5% concentration was prepared in phosphate-buffered saline for each antimicrobial compound. Serial dilutions (0.2, 0.1, and 0.05%) were prepared from the stock solution in microcentrifuge tubes to a volume of 90 1.1.1. The test organism (10 uI; 10 to 10 CFU/ml) was added to each microcentrifuge tube, mixed thoroughly, and sampled immediately (0-min sample). The 0-min sample was spread plated on MHB agar. The samples were then incubated at 37°C in a humidified 5% CO2 incubator. Samples were evaluated after incubation at 30, 60, and 120 mm. At each sampling, appropriate dilutions were done in BPW, and plating was done on MHB agar. Viable organisms were enumerated after incubation in a humidified 5% CO2 incubator for 48 to 72 h. Each experiment was carried out at least three times.
RESULTS AND DISCUSSION

Screening of C. jejuni isolates for antibiotic resistance.
A total of 63 isolates were tested for their susceptibility to cefaclor, ciprofloxacin, tetracycline, erythromycin, gentamicin, trimethoprim-sulfamethoxazole, and am-0.2% Antimicrobial activities of cinnamaldehyde and carvacrol against C. jejuni strains. Cinnamaldehyde and carvacrol were tested at 0.05, 0.1, and 0.2% concentrations against C. jejuni strains at 0, 30, 60, and 120 mm, respectively. Figure 1 illustrates the rapid concentration-dependent inactivation of C. jejuni resistant strain H2a. Both compounds at 0.2% concentration completely inactivated the organism at all sampling points except for the H2a strain, which had 2.3 log survivors at 0 min for 0.2% carvacrol treatment (Table 2 ). Carvacrol at 0.05 or 0.1% was not effective against all three C. jejuni isolates tested at all sampling points. By contrast, 0.1% cinnamaldehyde completely inactivated Strains D28a and H2a at all sampling points, and the A24a strain at 30 mm. Cinnamaldehyde at 0.05% reduced the population of the A24a strain by about 2 log at 60 mm; no survivors were detected at 120 min of sampling. For strain D28a, the population was reduced by about 1 log at 60 mm; no survivors were detected at 120 mm, with 0.05% cinnamaldehyde. With strain H2a, 0.05% cinnamaldehyde induced about a I-log reduction at 120 mm, showing that this strain was slightly more resistant than others were to 0.05% cinnamaldehyde. These observations indicate that cinnamaldehyde also exhibited stronger antimicrobial activity against C. jejuni isolates than did carvacrol.
In conclusion, the results of the present and previous in vitro studies suggest that plaht-derived compounds can inactivate both antibiotic-resistant and nonresistant strains of foodborne pathogens. Because the susceptibilities to inactivation of both types of pathogens (resistant and nonresistant) appear similar, the same mechanisms probably govern the inactivation of resistant and nonresistant microorganisms. These studies provide candidates for incorporation into formulations-safe and effective antimicrobial plant compounds that can reduce antibiotic-resistant pathogens in animal feeds, human foods, and in medicine. Hence, such cost-effective formulations merit further studies designed to determine whether they have the potential to protect animal feeds, human foods, animals, and humans against antibiotic-resistant C. jejuni and possibly other resistant pathogens. We are therefore extending the successful in vitro observations of the present study that describes the efficacies of plant antimicrobials against resistant C. jejuni to studies of antimicrobial activities in foods.
